IN2014CN04326A - - Google Patents

Download PDF

Info

Publication number
IN2014CN04326A
IN2014CN04326A IN4326CHN2014A IN2014CN04326A IN 2014CN04326 A IN2014CN04326 A IN 2014CN04326A IN 4326CHN2014 A IN4326CHN2014 A IN 4326CHN2014A IN 2014CN04326 A IN2014CN04326 A IN 2014CN04326A
Authority
IN
India
Prior art keywords
biomarkers
pregnancy
monitoring
devices
application discloses
Prior art date
Application number
Other languages
English (en)
Inventor
Gregoire Thomas
Robin Tuytten
Piet Moerman
Original Assignee
Pronota Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pronota Nv filed Critical Pronota Nv
Publication of IN2014CN04326A publication Critical patent/IN2014CN04326A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN4326CHN2014 2011-12-15 2012-12-14 IN2014CN04326A (cs)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161576273P 2011-12-15 2011-12-15
EP11193847 2011-12-15
US201261650145P 2012-05-22 2012-05-22
EP12168955 2012-05-22
PCT/EP2012/075643 WO2013087887A2 (en) 2011-12-15 2012-12-14 Biomarkers and parameters for hypertensive disorders of pregnancy

Publications (1)

Publication Number Publication Date
IN2014CN04326A true IN2014CN04326A (cs) 2015-09-04

Family

ID=48613303

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4326CHN2014 IN2014CN04326A (cs) 2011-12-15 2012-12-14

Country Status (10)

Country Link
US (1) US20140349881A1 (cs)
EP (1) EP2791683B1 (cs)
CN (1) CN104136924B (cs)
AU (1) AU2012351504C1 (cs)
BR (1) BR112014014456A2 (cs)
CA (1) CA2859295A1 (cs)
IN (1) IN2014CN04326A (cs)
RU (1) RU2673074C2 (cs)
WO (1) WO2013087887A2 (cs)
ZA (1) ZA201404319B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX395376B (es) * 2015-07-15 2025-03-25 Gestvision Inc Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
JP2018533745A (ja) * 2015-09-21 2018-11-15 4シー ダイアグノスティクス リミテッド4C Diagnostics Ltd. 便試料の収集、サンプリングおよび診断手段ならびにその方法
WO2017181367A1 (en) * 2016-04-20 2017-10-26 Ldx Prognostics Limited Co. Methods and compositions for prognosing preterm birth
US20190346452A1 (en) * 2016-05-17 2019-11-14 Ldx Prognostics Limited Co. Methods and compositions for providing preeclampsia assessment
CN106086182B (zh) * 2016-06-17 2019-06-07 李永旺 Pcyox1蛋白在作为缺血性脑卒中生物标志物中的应用
FR3059550B1 (fr) * 2016-12-01 2020-01-03 Universite De Rouen Normandie Traitement des troubles causes par l'alcoolisation foetale (tcaf)
WO2019155075A1 (en) * 2018-02-09 2019-08-15 Metabolomic Diagnostics Limited Methods of predicting pre term birth from preeclampsia using metabolic and protein biomarkers
RU2691114C1 (ru) * 2018-03-20 2019-06-11 федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования развития преэклампсии в поздние сроки беременности
CN108776226B (zh) * 2018-04-08 2021-03-19 邓成 晚发型子痫前期快速筛查用试纸和试剂盒
AU2019275491B2 (en) * 2018-05-24 2025-05-29 The University Of Melbourne Circulatory biomarkers for placental or fetal health
KR20200049365A (ko) * 2018-10-31 2020-05-08 서울대학교산학협력단 임신성 당뇨 및 임신 중 고혈압 예측을 위한 바이오마커
CN111933216B (zh) * 2019-05-13 2024-02-27 南方医科大学珠江医院 肠道微生物作为子痫前期生物标志物的用途
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
KR102302742B1 (ko) * 2019-12-31 2021-09-15 의료법인 성광의료재단 임신중독증 진단용 바이오마커 조성물 및 이의 용도
KR102233909B1 (ko) * 2020-07-13 2021-03-30 서울대학교산학협력단 임신성 당뇨 및 임신 중 고혈압 예측을 위한 바이오마커
RU2751139C1 (ru) * 2020-12-03 2021-07-08 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ прогнозирования риска развития преэклампсии у беременных с сахарным диабетом 1 и 2 типов
RU2767912C1 (ru) * 2021-02-12 2022-03-22 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ прогнозирования риска развития преэклампсии у беременных с различными типами сахарного диабета
EP4616198A1 (en) * 2022-11-10 2025-09-17 Metabolomic Diagnostics Limited A method of early prediction of risk of pre-term pre-eclampsia in specific population cohorts
CN115575646B (zh) * 2022-11-21 2023-04-28 四川大学华西医院 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途
KR20250079482A (ko) * 2023-11-27 2025-06-04 의료법인 성광의료재단 임신 초기 임신중독증 예측 및 진단을 위한 질환 특이적인 바이오마커 및 그의 용도
KR20250079483A (ko) * 2023-11-27 2025-06-04 의료법인 성광의료재단 임신 중기 임신중독증 예측 및 진단을 위한 질환 특이적인 바이오마커 및 그의 용도

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8331514D0 (en) 1983-11-25 1984-01-04 Janssen Pharmaceutica Nv Visualization method
US5514602A (en) 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US4853335A (en) 1987-09-28 1989-08-01 Olsen Duane A Colloidal gold particle concentration immunoassay
US4859612A (en) 1987-10-07 1989-08-22 Hygeia Sciences, Inc. Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
GB8800702D0 (en) 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
US5202267A (en) 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
US5108889A (en) 1988-10-12 1992-04-28 Thorne, Smith, Astill Technologies, Inc. Assay for determining analyte using mercury release followed by detection via interaction with aluminum
US5079172A (en) 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
US5141850A (en) 1990-02-07 1992-08-25 Hygeia Sciences, Inc. Porous strip form assay device method
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US6027944A (en) 1990-11-22 2000-02-22 Applied Research Systems Ars Holding Nv Capillary-fill biosensor device comprising a calibration zone
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6206829B1 (en) 1996-07-12 2001-03-27 First Opinion Corporation Computerized medical diagnostic and treatment advice system including network access
US6107045A (en) 1994-06-30 2000-08-22 Oklahoma Medical Research Foundation Antibodies to lipoproteins and apolipoproteins and methods of use thereof
WO1996036878A1 (en) 1995-05-19 1996-11-21 Universal Healthwatch, Inc. Rapid self-contained assay format
US5681775A (en) 1995-11-15 1997-10-28 International Business Machines Corporation Soi fabrication process
US6001658A (en) 1996-09-13 1999-12-14 Diagnostic Chemicals Limited Test strip apparatus and method for determining presence of analyte in a fluid sample
US6511814B1 (en) 1999-03-26 2003-01-28 Idexx Laboratories, Inc. Method and device for detecting analytes in fluids
US6974706B1 (en) 2003-01-16 2005-12-13 University Of Florida Research Foundation, Inc. Application of biosensors for diagnosis and treatment of disease
AU1924101A (en) * 1999-11-22 2001-06-04 Human Genome Sciences, Inc. Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
EP2261669A1 (en) * 2001-05-04 2010-12-15 Alere San Diego, Inc. Diagnostic markers of acute coronary syndromes and methods of use thereof
US20030109067A1 (en) 2001-12-06 2003-06-12 Immunetech, Inc. Homogeneous immunoassays for multiple allergens
ES2534294T3 (es) * 2002-07-19 2015-04-21 Beth Israel Deaconess Medical Center Métodos para tratar la preeclampsia
CA2838007A1 (en) 2004-11-15 2006-05-26 University Of North Dakota A method for single oxygen atom incorporation into digested peptides using peptidases
US20100190192A1 (en) * 2005-09-15 2010-07-29 Victor Voroteliak Method of diagnosing pre-eclampsia
GB0600916D0 (en) * 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
CN101063677B (zh) * 2006-04-30 2012-07-25 安徽省生物医学研究所 一种预测妊娠不良结局发生风险的试剂盒
US7749773B2 (en) 2006-10-11 2010-07-06 Day Alan R Device for detection of molecules in biological fluids
EP2038431A1 (en) * 2007-02-01 2009-03-25 Diagnostic Technologies Ltd. Method for determining preeclampsia risk
WO2009094665A1 (en) * 2008-01-25 2009-07-30 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
US20100016173A1 (en) 2008-01-30 2010-01-21 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009108073A1 (en) 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease
WO2010059952A1 (en) * 2008-11-20 2010-05-27 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers
KR101070247B1 (ko) * 2009-01-30 2011-10-06 건국대학교 산학협력단 프로테오믹스기법을 이용한 임신중독 특이 표지 단백질 및 진단방법
CA2793487A1 (en) * 2010-04-13 2011-10-20 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy

Also Published As

Publication number Publication date
ZA201404319B (en) 2015-06-24
CN104136924B (zh) 2018-05-29
AU2012351504A1 (en) 2014-08-07
US20140349881A1 (en) 2014-11-27
AU2012351504C1 (en) 2018-04-26
CN104136924A (zh) 2014-11-05
EP2791683B1 (en) 2017-11-15
AU2012351504B2 (en) 2018-01-04
RU2014128845A (ru) 2016-02-10
RU2673074C2 (ru) 2018-11-22
BR112014014456A2 (pt) 2018-09-25
WO2013087887A2 (en) 2013-06-20
EP2791683A2 (en) 2014-10-22
CA2859295A1 (en) 2013-06-20
WO2013087887A3 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
IN2014CN04326A (cs)
WO2012076553A3 (en) Biomarkers and parameters for hypertensive disorders of pregnancy
WO2011128357A3 (en) Biomarkers for hypertensive disorders of pregnancy
WO2013083781A3 (en) Biomarkers and test panels useful in systemic inflammatory conditions
GB201021289D0 (en) Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
MX2019015159A (es) Composiciones, metodos y usos para asistir en el diagnostico, pronostico y tratamiento de la fibrosis pulmonar idiopatica.
EA201390149A1 (ru) Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
MX2015010174A (es) Herramientas de diagnostico para predecir la presentacion de preeclampsia.
MX2013010035A (es) Prediccion de neoplasmas neuroendocrinos gastroenteropancreaticos (gep-nens).
EP2387618A4 (en) PANEL OF BIOMARKERS FOR DIAGNOSIS AND PREDICTION OF GRAFT REJECTION
WO2013159872A8 (en) Biomarkers for the diagnosis, prognosis, assessment and therapy stratification of syncope
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
NZ630421A (en) Biomarkers predictive for clinical response for glatiramer acetate
WO2013153461A3 (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
WO2014209905A3 (en) Methods and compositions for detecting and diagnosing diseases and conditions
EP2660310A4 (en) COMPREHENSIVE GLAUCOMOTIC PROCESS WITH A GLAUKOM DIAGNOSIS CHIP AND A CLUSTER ANALYSIS OF A DEFORMED PROTEOMIC
WO2011130647A3 (en) Compositions and methods for characterizing a myopathy
WO2014047442A3 (en) Biomarkers for assessing treatment of sialic acid deficiency diseases and conditions
AU2010209763A8 (en) Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
WO2012139051A3 (en) Autoantibody biomarkers for iga nephropathy
WO2011083461A3 (en) Method for diagnosing and monitoring schizophrenia and tauopathies